CPhI 2011: Fine Chemicals Firms Upbeat, But Questions Arise Over Outlook

摘要

Several key manufacturers of active pharmaceutical ingredients (API) and pharmaceutical intermediates interviewed by CW at the CPhI show in Frankfurt today say that the market is buoyant and they are continuing to grow their businesses. The heads of Sigma Aldrich Fine Chemicals (SAFC) and Carbogen- Amis warn, however, that with billions of dollars of sales of innovator pharma- ceuticals about to come off patent in 2012 the contract manufacturing sector could be about to face a period of consolidation. BASF custom synthesis business has been unaffected by the global economic uncertainty.